Unknown

Dataset Information

0

MiR-195 Inhibits Tumor Progression by Targeting RPS6KB1 in Human Prostate Cancer.


ABSTRACT: To investigate the involvement of hsa-miRNA-195-5p (miR-195) in progression and prognosis of human prostate cancer.qRT-PCR was performed to detect miR-195 expression in both prostate cancer cell lines and clinical tissue samples. Its clinical significance was statistically analyzed. The roles of miR-195 and its candidate target gene, ribosomal protein S6 kinase, 70 kDa, polypeptide 1 (RPS6KB1) in prostate cancer progression were confirmed on the basis of both in vitro and in vivo systems.miR-195 downregulation in prostate cancer tissues was significantly associated with high Gleason score (P = 0.001), positive metastasis failure (P < 0.001), and biochemical recurrence (BCR, P < 0.001). Survival analysis identified miR-195 as an independent prognostic factor for BCR-free survival of prostate cancer patients (P = 0.022). Then, we confirmed the tumor suppressive role of miR-195 through prostate cancer cell invasion, migration, and apoptosis assays in vitro, along with tumor xenograft growth, angiogenesis, and invasion in vivo according to both gain-of-function and loss-of-function experiments. In addition, RPS6KB1 was identified as a novel direct target of miR-195 through proteomic expression profiling combined with bioinformatic target prediction and luciferase reporter assay. Moreover, the reexpression and knockdown of RPS6KB1 could respectively rescue and imitate the effects induced by miR-195. Importantly, RPS6KB1 expression was closely correlated with aggressive progression and poor prognosis in prostate cancer patients as opposed to miR-195. Furthermore, we identified MMP-9, VEGF, BAD, and E-cadherin as the downstream effectors of miR-195-RPS6KB1 axis.The newly identified miR-195-RPS6KB1 axis partially illustrates the molecular mechanism of prostate cancer progression and represents a novel potential therapeutic target for prostate cancer treatment.

SUBMITTER: Cai C 

PROVIDER: S-EPMC4631653 | biostudies-literature | 2015 Nov

REPOSITORIES: biostudies-literature

altmetric image

Publications

miR-195 Inhibits Tumor Progression by Targeting RPS6KB1 in Human Prostate Cancer.

Cai Chao C   Chen Qing-Biao QB   Han Zhao-Dong ZD   Zhang Yan-Qiong YQ   He Hui-Chan HC   Chen Jia-Hong JH   Chen Yan-Ru YR   Yang Sheng-Bang SB   Wu Yong-Ding YD   Zeng Yan-Ru YR   Qin Guo-Qiang GQ   Liang Yu-Xiang YX   Dai Qi-Shan QS   Jiang Fu-Neng FN   Wu Shu-lin SL   Zeng Guo-Hua GH   Zhong Wei-De WD   Wu Chin-Lee CL  

Clinical cancer research : an official journal of the American Association for Cancer Research 20150616 21


<h4>Purpose</h4>To investigate the involvement of hsa-miRNA-195-5p (miR-195) in progression and prognosis of human prostate cancer.<h4>Experimental design</h4>qRT-PCR was performed to detect miR-195 expression in both prostate cancer cell lines and clinical tissue samples. Its clinical significance was statistically analyzed. The roles of miR-195 and its candidate target gene, ribosomal protein S6 kinase, 70 kDa, polypeptide 1 (RPS6KB1) in prostate cancer progression were confirmed on the basis  ...[more]

Similar Datasets

| S-EPMC4674136 | biostudies-literature
| S-EPMC4818461 | biostudies-literature
| S-EPMC4105551 | biostudies-literature
| S-EPMC7196466 | biostudies-literature
| S-EPMC7350594 | biostudies-literature
| S-EPMC5436519 | biostudies-other
| S-EPMC5731849 | biostudies-literature
| S-EPMC6667922 | biostudies-literature
| S-EPMC6171160 | biostudies-literature